# RITTER PHARMACEUTICALS INC (RTTR)

> Institutional ownership reported to the SEC as of Q1 2020, from Form 13F filings. Source: https://holderbook.com/stocks/RTTR/

- Reporting holders: 10
- Reported value: $1.2M
- Held through calls: 94.7%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Alyeska Investment Group, L.P.](https://holderbook.com/funds/1453072-alyeska-investment-group-l-p/) | $1.1M | 0 | 0.0% | 6 |
| [VANGUARD GROUP INC](https://holderbook.com/funds/102909-vanguard-group-inc/) | $24.0K | 91,096 | 0.0% | 6 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $14.0K | 53,925 | 0.0% | 1 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $7.0K | 25,026 | 0.0% | 1 |
| [BlackRock Inc.](https://holderbook.com/funds/1364742-blackrock-inc/) | $4.0K | 15,081 | 0.0% | 6 |
| [TWO SIGMA SECURITIES, LLC](https://holderbook.com/funds/1450144-two-sigma-securities-llc/) | $4.0K | 16,296 | 0.0% | 2 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $4.0K | 13,848 | 0.0% | 2 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $3.0K | 12,000 | 0.0% | 1 |
| [VICTORY CAPITAL MANAGEMENT INC](https://holderbook.com/funds/1040188-victory-capital-management-inc/) | $2.0K | 8,648 | 0.0% | 1 |
| [AdvisorNet Financial, Inc](https://holderbook.com/funds/1409362-advisornet-financial-inc/) | $1.0K | 4,000 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2020 | 10 | $1.2M |
| Q4 2019 | 8 | $832.0K |
| Q3 2019 | 7 | $1.6M |
| Q2 2019 | 11 | $5.2M |
| Q1 2019 | 12 | $4.2M |
| Q4 2018 | 11 | $3.0M |